Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |